Search for: All records

Background: The primary hot rolling method implemented is differential speed rolling(DSR). The material is rolled and grains are strained, producing fine dynamic recrystallization(DRX) grains that improve material strength and ductility. Objective: The material introduced and under investigation in this paper is an Mg-based alloy,Mg5Zn (wt. %), whose microstructure is enhanced through a combination of heat treatments withproper temperature and holding time and subsequent plastic deformation through hot rolling toevaluate the effect on mechanical properties Methods: The method involves preheating the material to various temperatures in a range from250ºC to 350ºC and rolling to various thickness reductions to analyze the effect of single-pass differentialspeed rolling (DSR) and conventional rolling (CR) on the DRX process and its influenceon mechanical properties. Results: The effect of single-pass differential speed rolling (DSR) and conventional rolling (CR)on the DRX process shows that the process produces increasing amounts of finer DRX grains athigher rolling reductions, thereby improving the strength and ductility of the material. Conclusion: This investigation demonstrated that single-pass DSR can improve the mechanicalproperties and formability of Mg5Zn more effectively than CR in terms of grain refinement analyzedthrough OM, SEM, and EBSD resulting in enhanced tensile strength and ductility [1]. 

The present work mainly investigated the effect of extrusion temperatures on the microstructure and mechanical properties of Mg-1.3Zn-0.5Ca (wt.%) alloys. The alloys were subjected to extrusion at 300 °C, 350 °C, and 400 °C with an extrusion ratio of 9.37. The results demonstrated that both the average size and volume fraction of dynamic recrystallized (DRXed) grains increased with increasing extrusion temperature (DRXed fractions of 0.43, 0.61, and 0.97 for 300 °C, 350 °C, and 400 °C, respectively). Moreover, the as-extruded alloys exhibited a typical basal fiber texture. The alloy extruded at 300 °C had a microstructure composed of fine DRXed grains of ~1.54 µm and strongly textured elongated unDRXed grains. It also had an ultimate tensile strength (UTS) of 355 MPa, tensile yield strength (TYS) of 284 MPa, and an elongation (EL) of 5.7%. In contrast, after extrusion at 400 °C, the microstructure was almost completely DRXed with a greatly weakened texture, resulting in an improved EL of 15.1% and UTS of 274 MPa, TYS of 220 MPa. At the intermediate temperature of 350 °C, the alloy had a UTS of 298 MPa, TYS of 234 MPa, and EL of 12.8%. 

Magnesium (Mg)-based alloys have the potential for bone repair due to their properties of biodegradation, biocompatibility, and structural stability, which can eliminate the requirement for a second surgery for the removal of the implant. Nevertheless, uncontrolled degradation rate and possible cytotoxicity of the corrosion products at the implant sites are known current challenges for clinical applications. In this study, we assessed in vitro cytotoxicity of different concentrations (0 to 50 mM) of possible corrosion products in the form of magnesium oxide (MgO) and magnesium hydroxide (Mg(OH)2) nanoparticles (NPs) in human fetal osteoblast (hFOB) 1.19 cells. We measured cell proliferation, adhesion, migration, and cytotoxicity using a real-time, label-free, non-invasive electric cell-substrate impedance sensing (ECIS) system. Our results suggest that 1 mM concentrations of MgO/Mg(OH)2 NPs are tolerable in hFOB 1.19 cells. Based on our findings, we propose the development of innovative biodegradable Mg-based alloys for further in vivo animal testing and clinical trials in orthopedics. 

Engineered composite scaffolds composed of natural and synthetic polymers exhibit cooperation at the molecular level that closely mimics tissue extracellular matrix's (ECM) physical and chemical characteristics. However, due to the lack of smooth intermix capability of natural and synthetic materials in the solution phase, bio‐inspired composite material development has been quite challenged. In this research, we introduced new bio‐inspired material blending techniques to fabricate nanofibrous composite scaffolds of chitin nanofibrils (CNF), a natural hydrophilic biomaterial and poly (ɛ‐caprolactone) (PCL), a synthetic hydrophobic‐biopolymer. CNF was first prepared by acid hydrolysis technique and dispersed in trifluoroethanol (TFE); and second, PCL was dissolved in TFE and mixed with the chitin solution in different ratios. Electrospinning and spin‐coating technology were used to form nanofibrous mesh and films, respectively. Physicochemical properties, such as mechanical strength, and cellular compatibility, and structural parameters, such as morphology, and crystallinity, were determined. Toward the potential use of this composite materials as a support membrane in blood–brain barrier application (BBB), human umbilical vein endothelial cells (HUVECs) were cultured, and transendothelial electrical resistance (TEER) was measured. Experimental results of the composite materials with PCL/CNF ratios from 100/00 to 25/75 showed good uniformity in fiber morphology and suitable mechanical properties. They retained the excellent ECM‐like properties that mimic synthetic‐bio‐interface that has potential application in biomedical fields, particularly tissue engineering and BBB applications.

 

Nano-in-micro (NIM) system is a promising approach to enhance the performance of devices for a wide range of applications in disease treatment and tissue regeneration. In this study, polymeric nanofibre-integrated alginate (PNA) hydrogel microcapsules were designed using NIM technology. Various ratios of cryo-ground poly (lactide-co-glycolide) (PLGA) nanofibres (CPN) were incorporated into PNA hydrogel microcapsule. Electrostatic encapsulation method was used to incorporate living cells into the PNA microcapsules (~500 µm diameter). Human liver carcinoma cells, HepG2, were encapsulated into the microcapsules and their physio-chemical properties were studied. Morphology, stability, and chemical composition of the PNA microcapsules were analysed by light microscopy, fluorescent microscopy, scanning electron microscopy (SEM), Fourier-Transform Infrared spectroscopy (FTIR), and thermogravimetric analysis (TGA). The incorporation of CPN caused no significant changes in the morphology, size, and chemical structure of PNA microcapsules in cell culture media. Among four PNA microcapsule products (PNA-0, PNA-10, PNA-30, and PNA-50 with size 489 ± 31 µm, 480 ± 40 µm, 473 ± 51 µm and 464 ± 35 µm, respectively), PNA-10 showed overall suitability for HepG2 growth with high cellular metabolic activity, indicating that the 3D PNA-10 microcapsule could be suitable to maintain better vitality and liver-specific metabolic functions. Overall, this novel design of PNA microcapsule and the one-step method of cell encapsulation can be a versatile 3D NIM system for spontaneous generation of organoids within vivolike tissue architectures, and the system can be useful for numerous biomedical applications, especially for liver tissue engineering, cell preservation, and drug toxicity study.